Genzyme Corporation (Nasdaq: GENZ) announced that it has submitted the final documentation to address all items in the FDA's complete ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE